Centaurus Financial’s NantHealth, Inc NH Stock Holding History

Centaurus Financial’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-53	Closed	-$3K	–	2206
2018 Q2	$3K	Buy	+53	New	+$2.62K	﹤0.01%	1962

Other funds holding NH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centaurus Financial's NH Position: Q3 2018 in Review

Centaurus Financial sold out of NantHealth, Inc (NH) in Q3 2018, closing a stake of 53 shares — an estimated $3K sold.

Centaurus Financial first reported a position in NH in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 46 funds tracked by Wall St. Rank hold NH as of Q3 2018.

Centaurus Financial reported no remaining NantHealth, Inc position as of Q3 2018 after selling out during the quarter.
Centaurus Financial sold 53 NantHealth, Inc shares in Q3 2018, an estimated $3K.
Centaurus Financial first reported a position in NantHealth, Inc in Q2 2018 and held it in 1 quarter.
Centaurus Financial's NantHealth, Inc position peaked at $3K in Q2 2018.
46 funds tracked by Wall St. Rank held NantHealth, Inc as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.